Cost-Effectiveness Analysis of Denosumab in the Treatment of Chinese Postmenopausal Women and Men with Osteoporosis

ZHANG Mengqian, JIANG Xiaobing, HE Xiaoning

Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (11) : 1057-1064.

PDF(1206 KB)
PDF(1206 KB)
Chinese Pharmaceutical Journal ›› 2024, Vol. 59 ›› Issue (11) : 1057-1064. DOI: 10.11669/cpj.2024.11.013

Cost-Effectiveness Analysis of Denosumab in the Treatment of Chinese Postmenopausal Women and Men with Osteoporosis

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 59(11): 1057-1064 https://doi.org/10.11669/cpj.2024.11.013

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1206 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉